Changchun High-Tech Industry (Group) Co., Ltd. (SHE:000661)
China · Delayed Price · Currency is CNY 128.00
+8.96 (7.53%)
Sep 5, 2025, 3:04 PM CST
SHE:000661 Revenue
Changchun High-Tech Industry (Group) had revenue of 3.61B CNY in the quarter ending June 30, 2025, with 4.16% growth. This brings the company's revenue in the last twelve months to 13.43B, down -10.69% year-over-year. In the year 2024, Changchun High-Tech Industry (Group) had annual revenue of 13.47B, down -7.55%.
Revenue (ttm)
13.43B
Revenue Growth
-10.69%
P/S Ratio
3.84
Revenue / Employee
1.16M
Employees
11,547
Market Cap
51.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.47B | -1.10B | -7.55% |
| Dec 31, 2023 | 14.57B | 1.94B | 15.35% |
| Jan 1, 2023 | 12.63B | 1.88B | 17.50% |
| Jan 1, 2022 | 10.75B | 2.17B | 25.30% |
| Dec 31, 2020 | 8.58B | 1.20B | 16.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |